Alterity Therapeutics Limited
Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Parkinsonian's disease and other neurodegenerative diseases in Australia. The company's lead drug candidates is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 for used as an antimicrobial agent. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. The company was founded in 1997 and is based in Melbourne, Australia. Show More...
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 4.50 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-06 2011-06 2012-06 2013-06 2014-06 2015-06 2016-06 2017-06 2018-06 2019-06 TTM Earnings Per Share AUD -1.3 -1.56 -1.09 -1.38 -1.87 -0.7 -0.87 -0.84 -0.93 -1.2 -0.99 Dividends AUD Payout Ratio % * Shares Mil 4.0 4.0 5.0 6.0 7.0 8.0 9.0 9.0 9.0 10.0 13.0 Book Value Per Share * USD 1.14 1.61 1.11 1.38 2.28 3.15 3.04 2.38 1.66 0.53 0.51 Free Cash Flow Per Share * USD -1.06 -1.18 -1.16 -1.36 -1.47 -1.42 -0.84 -0.05 -0.53 -0.97 Return on Assets % -86.1 -81.34 -64.08 -63.79 -45.4 -14.1 -20.46 -25.56 -37.57 -63.87 -88.28 Financial Leverage (Average) 1.3 1.3 1.31 1.22 1.1 1.07 1.08 1.07 1.16 1.2 1.29 Return on Equity % -109.3 -105.77 -83.47 -79.47 -51.6 -15.33 -21.93 -27.4 -41.57 -75.61 -114.26 Return on Invested Capital % -109.3 -105.71 -79.5 -75.07 -51.49 -15.33 -21.93 -27.4 -41.57 -75.61 -114.26 Interest Coverage -452.87 -439.55 -443.63 Current Ratio 4.47 4.3 4.24 5.48 10.51 15.35 14.28 15.88 7.06 5.98 4.43 Quick Ratio 3.48 4.26 4.2 5.44 10.5 15.3 14.16 15.7 6.96 5.79 4.34 Debt/Equity